NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression

Viral Immunology

Volumn 9, Issue 2, 1996, Pages 131-140

  Weinberg, Adriana ^a,c   Zhang, Li ^a   Tuder, Rubin M ^b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CYTOMEGALOVIRUS; CYTOTOXICITY; ENDOTHELIUM CELL; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; MONONUCLEAR CELL; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MURINAE;

EID: 0029887357     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.131     Document Type: Article

References (25)

1. Bishop, G.A., J.C. Glorioso, and S.A. Schwartz. 1983. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J. Exp. Med. 157:1544-1561.
2. Borysiewicz, L.K., B. Rodgers, S. Morris, S. Graham, and J.G.P. Sissons. 1985. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells:demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. J. Immunol. 134:2695.
3. Bostrom, L., O. Ringden, B. Sundberg, A. Linde, J. Tollemar, and B. Nilsson. 1988. Pretransplant herpesvirus serology and acute graft-versus-host disease. Transplantation 46:548.
4. Cheng, Y-C., E-S. Huang, J-C. Lin, E-C. Mar, J-S. Pagano, C-E. Dutschman, and S-P. Grill. 1983. Unique spectrum of activity of 9-[1,3-dihydroxy-2-propoxy)methyl]-quanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc. Natl. Acad. Sci. U.S.A. 80:2767.
5. Correa, I., N.S. Liao, and D. Raulet. 1992. Role of class I MHC and self peptides in NK recognition. J. Cell. Biochem. 160:60.
6. Fitzgerald-Bocarsly, P., D.M. Howell, L. Pettera, S. Tehrani, and C. Lopez. 1991. Immediate-early gene expression if sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts. J. Exp. Med. 65:3151.
7. Gleaves, C.A., T.J. Smith, E.A. Shuster, and G.R. Pearson. 1984. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J. Clin. Microbiol. 19:917.
8. Grattan, M.T., C.E. Moreno-Cabral, V.A. Starnes, P.E. Oyer, E.B. Stinson, and N.E. Shumway. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 26:3561.
9. Greenberg, P., J. Goodrich, and S. Riddell. 1991. Adoptive immunotherapy of human cytomegalovirus infection: Potential role in protection from disease progression. Transplant. Proc. 23:97.
10. Herberman, R.B., J.R. Ortaldo, and G.D. Bonnard. 1979. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature (London) 227:221.
11. Hughes, C.C.W., C.O.S. Savage, and J.S. Pober. 1990. The endothelial cell as a regulator of T-cell function. Immunol. Rev. 117:85.
12. Kaufman, D.S., R.A. Schoon, and P.J. Leibson. 1993. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J. Immunol. 150:1429.
13. Kaufman, D.S., R.A. Schoon, and P.J. Leibson. 1992. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc. Natl. Acad. Sci. U.S.A. 89:8337.
14. Leibson, P.J., M. Hunter-Laszlo, and A.R. Hayward. 1986. Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells. J. Virol. 57:976.
15. Malnati, M.S., P. Lusso, E. Ciccone, A. Moretta, L. Moretta, and E.O. Long. 1993. Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J. Exp. Med. 178:961.
16. O'Grady, J.G., S. Sutherland, F. Harvey, R.Y. Calne, G.J.M. Alexander, P.T. Donaldson, B. Portmann, and R. Williams. 1988. Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent co-factors in pathogenesis of vanishing bile duct syndrome after transplantation. Lancet ii:302.
17. Peterson, P.K., H.H. Balfour, S.C. Marker, D.S. Fryd, R.J. Howard, and R.L. Simmons. 1980. Cytomegalovirus disease in renal allograft recipients: A prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 59:283.
18. Quinnan, G.V., N. Kirmani, A.H. Rook, J.F. Manishewitz, L. Jackson, G. Moreschi, G.W. Santos, R. Saral, and W.H. Bums. 1982. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted and T lymphocyte and non-T lymphocyte responses correlate with recovery from cytomegalovirus in bone marrow transplant recipients. N. Engl. J. Med. 307:6.
19. Riddell, S.R., M. Rabin, A.P. Geballe, W.J. Britt, and P.D. Greenberg. 1991. Class I MHC restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146:2795-2804.
20. Starr, S.E., and T. Garrabrant. 1981. Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leukocytes. Clin. Exp. Immunol. 46:484-492.
21. Storkus, W.J., and J.R. Dawson. 1991. Target structures involved in natural killing: Characteristics, distribution, and candidate molecules. CRC Crit. Rev. Immunol. 10:393.
22. Tuder, R.M., A. Weinberg, N. Panajotopoulos, and J. Kalil. 1994. Cytomegalovirus infection amplifies class I MHC expression on cultured human endothelial cells. J. Heart Lung Transplant. 13:129.
23. van Dorp, W.T., E. Jonges, C.A. Bruggeman, M.R. Daha, L.A. van Es, F.J. van Der Woude. 1989. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 48:469.
24. Weinberg, A., and T.C. Merigan. 1988. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. J. Immunol. 140:294.
25. Weinberg, A., T.Y. Basham, and T.C. Merigan. 1987. Regulation of the guinea pig immune function by interleukin-2: Critical role of natural killer activity in acute HSV-2 genital infection. J. Immunol. 137:3310.